Psoriasis: Clinical Trials

3 trials for Psoriasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 suspended. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Suspended 3

Follow Psoriasis: new trials by email Literature Review of Psoriasis trials Research Report on Psoriasis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis
IRX4204, Placebo - Psoriasis, Plaque Type Psorisis
Phase 2SuspendedIo Therapeutics202027-03-012026-11-12
Study to Test the Effectiveness of a New Treatment for Scalp Psoriasis
DPS-102, Vehicle / Placebo, Calcipotriol Monotherapy - Psoriasis
Phase 2SuspendedDermiPsor, Ltd.1602013-04-012011-06-08
Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate
mometasone furoate + salicylic acid, Mometasone furoate - Plaque Psoriasis
Phase 2SuspendedAzidus Brasil402006-09-012022-11-03

Narrower conditions

Plaque, Amyloid (1)

Broader conditions

Skin Diseases (3)  ·  Skin Diseases, Papulosquamous (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

AGN 194204 (1)  ·  IRX4204 (1)  ·  Mometasone Furoate (1)  ·  Salicylic Acid (1)

Sponsors

Azidus Brasil (1)  ·  DermiPsor, Ltd. (1)  ·  Io Therapeutics (1)

Countries

United States (2)

Top investigators

Alexandre Frederico, Doctor (1)  ·  Carolyn Stanger (1)  ·  Nancy Naguib, M.D. (1)  ·  Nelli Konnikov, M.D. (1)  ·  Shay Marcus (1)